MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Intuitive Surgical Inc

Открыт

СекторЗдравоохранение

508.68 1.05

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

503.3

Макс.

513.24

Ключевые показатели

By Trading Economics

Доход

123M

688M

Продажи

374M

2.4B

P/E

Средняя по отрасли

72.947

57.333

Прибыль на акцию

2.21

Рентабельность продаж

28.506

Сотрудники

15,638

EBITDA

116M

810M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+16.53% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-39B

168B

Предыдущая цена открытия

507.63

Предыдущая цена закрытия

508.68

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Intuitive Surgical Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

22 апр. 2025 г., 20:55 UTC

Отчет

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 янв. 2025 г., 21:41 UTC

Отчет

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 янв. 2025 г., 18:37 UTC

Приобретения, слияния, поглощения

Intuitive to Establish Direct Presence in Europe With Acquisition

18 окт. 2024 г., 15:22 UTC

Отчет
Главные движущие силы рынка

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17 окт. 2024 г., 21:33 UTC

Отчет
Главные движущие силы рынка

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 окт. 2024 г., 20:56 UTC

Отчет

Intuitive Surgical Posts 3Q Revenue Growth

22 апр. 2025 г., 20:13 UTC

Отчет

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 апр. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 апр. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 апр. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 1Q Net $698.4M >ISRG

22 апр. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 апр. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 янв. 2025 г., 21:17 UTC

Отчет

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 янв. 2025 г., 18:18 UTC

Отчет

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 янв. 2025 г., 13:11 UTC

Главные новости

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 янв. 2025 г., 09:51 UTC

Популярные акции

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 янв. 2025 г., 21:10 UTC

Отчет

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 янв. 2025 г., 21:09 UTC

Отчет

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 янв. 2025 г., 21:09 UTC

Отчет

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 янв. 2025 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 янв. 2025 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 янв. 2025 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 янв. 2025 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Net $685.7M >ISRG

23 янв. 2025 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q EPS $1.88 >ISRG

15 янв. 2025 г., 17:27 UTC

Отчет

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6 янв. 2025 г., 12:00 UTC

Главные новости

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18 окт. 2024 г., 15:59 UTC

Отчет

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18 окт. 2024 г., 15:38 UTC

Отчет

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18 окт. 2024 г., 13:28 UTC

Отчет

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17 окт. 2024 г., 21:18 UTC

Отчет
Главные движущие силы рынка

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Сравнение c конкурентами

Изменение цены

Intuitive Surgical Inc Прогноз

Целевая цена

By TipRanks

16.53% рост

Прогноз на 12 месяцев

Средняя 592.13 USD  16.53%

Максимум 675 USD

Минимум 470 USD

Основано на мнении 18 аналитиков Wall Street, спрогнозировавших целевые цены для Intuitive Surgical Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

18 ratings

15

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

489.52 / 517.31Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Weak Bullish Evidence

Долгосрочная

Bearish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.